Iradimed Corp IRMD

$85.74 +1.81 (2.16%)

Valuation

Market cap
1,073,212,000
Revenue TTM
$83,810,000
Net income TTM
$22,480,000
PE ratio
46.90
Forward PE
42.51
Profit margin
26.82%
Debt to equity
0.00

Trading

Volume
92,600
Avg volume
116,388
Day's range
$84.80 – $86.93
Shares out
12,787,000
Stochastic %K
37%
Beta
0.91
Analysts
Strong Sell
Price target
$118.00

Price

Company profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 36...

Show more

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Industry
Medical Devices
Sector
Healthcare
Phone
407 677-8022
Website
https://www.iradimed.com
Address
12705 Ingenuity Drive, Orlando, United States

Latest news

Stocktwits

txbondman Sep 8, 6:33 PM
bot $COCO at 53.70; bot $IRMD at 84.73; bot $YOU at 43.40;
0 replies
EarningsInsider Aug 1, 5:02 AM
https://www.marketbeat.com/earnings/reports/2026-7-31-iradimed-co-stock/ $IRMD iRadimed Earnings Transcript
0 replies
StocktwitsEarnings Jul 31, 2:57 PM
$IRMD Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.41 down -8.89% YoY • Reported revenue of $20.47M up 0.28% YoY • For the third quarter of 2026, Iradimed expects revenue of $23.0 million to $24.5 million, GAAP diluted earnings per share of $0.49 to $0.54, and non-GAAP diluted earnings per share of $0.54 to $0.59.
0 replies
SuperGreenToday Jun 10, 1:00 PM
$IRMD Share Price: $96.52 Contract Selected: Jan 15, 2027 $95 Calls Buy Zone: $11.32 – $13.99 Target Zone: $21.54 – $26.32 Potential Upside: 80% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/
0 replies
parcha May 29, 10:12 PM
Final Trade: IRMD, GDX, DELL, SLG $IRMD $GDX $DELL $SLG https://www.cnbc.com/video/2026/05/29/final-trade-irmd-gdx-dell-slg.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 replies
StocktwitsEarnings May 1, 2:58 PM
$IRMD Q1 '26 Earnings Results & Recap Iradimed reaffirms full-year 2026 guidance with expected revenue of $91.0 million to $96.0 million, GAAP diluted EPS of $1.90 to $2.05, and non-GAAP diluted EPS of $2.06 to $2.21.
0 replies
Doozio Mar 26, 12:54 AM
$IRMD out of the tightness give YO a MRVLelous sign and all that JAZZ. 🐒🍌🧠⏰♾️
0 replies
ZacksResearch Mar 10, 2:57 PM
5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722
0 replies